Penumbra, Inc. (PEN)

NYSE: PEN · IEX Real-Time Price · USD
217.45
-5.01 (-2.25%)
Apr 12, 2024, 4:00 PM EDT - Market closed
-2.25%
Market Cap 8.42B
Revenue (ttm) 1.06B
Net Income (ttm) 90.95M
Shares Out 38.70M
EPS (ttm) 2.32
PE Ratio 93.73
Forward PE 76.01
Dividend n/a
Ex-Dividend Date n/a
Volume 170,230
Open 220.09
Previous Close 222.46
Day's Range 216.78 - 222.31
52-Week Range 180.93 - 348.67
Beta 0.53
Analysts Strong Buy
Price Target 298.55 (+37.3%)
Earnings Date May 7, 2024

About PEN

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, S... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Sep 18, 2015
Employees 4,200
Stock Exchange NYSE
Ticker Symbol PEN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for PEN stock is "Strong Buy." The 12-month stock price forecast is $298.55, which is an increase of 37.30% from the latest price.

Price Target
$298.55
(37.30% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market clos...

3 days ago - PRNewsWire

10 Companies To Watch In Q2 2024

Following our list of 50 Companies to Watch in January, we're back with 10 specifically for the second quarter based on scenarios from Bloomberg Intelligence. Catherine Lim explains why Chow Tai Fook ...

Other symbols: CRMOSKTCEHYTMHC
10 days ago - Bloomberg Markets and Finance

Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

ALAMEDA, Calif. , Feb. 22, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and ful...

7 weeks ago - PRNewsWire

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

ALAMEDA, Calif. , Feb. 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2023 aft...

2 months ago - PRNewsWire

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

ALAMEDA, Calif. , Dec. 18, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P.

4 months ago - PRNewsWire

First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism

First-of-its-kind randomized controlled trial comparing computer assisted vacuum thrombectomy (CAVT) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone Penumbra's Indi...

4 months ago - PRNewsWire

Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

ALAMEDA, Calif. , Nov. 14, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 35th Annual Healthcare Conference on Tu...

5 months ago - PRNewsWire

Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans

ALAMEDA, Calif., Nov. 10, 2023 /PRNewswire/ -- Everyday, memories of the people who served in World War II, Vietnam, and the Korean War are disappearing from living history.

5 months ago - PRNewsWire

Penumbra, Inc. Reports Third Quarter 2023 Financial Results

ALAMEDA, Calif. , Nov. 2, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter ended Sep...

5 months ago - PRNewsWire

NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES

Latest STRIKE-PE data show that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain; it also improved clinical and...

5 months ago - PRNewsWire

6 Medical Device Stocks Primed to Bounce Back

Some investors have worried that new weight-loss drugs could undermine demand for some medical devices.

Other symbols: BAXDXCMPODDRMDZBH
6 months ago - Barrons

Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023

ALAMEDA, Calif. , Oct. 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after market close...

6 months ago - PRNewsWire

Penumbra, Inc. to Present at Upcoming Investor Conferences

ALAMEDA, Calif. , Aug. 23, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times...

8 months ago - PRNewsWire

Top 5 Health Care Stocks That Could Blast Off In August

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: ALLRBIOLZVSA
9 months ago - Benzinga

Penumbra, Inc. Reports Second Quarter 2023 Financial Results

ALAMEDA, Calif. , Aug. 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended Ju...

9 months ago - PRNewsWire

Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference

ALAMEDA, Calif. , July 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 43rd Annual Growth Conference on We...

9 months ago - PRNewsWire

Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023

ALAMEDA, Calif. , July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market clos...

10 months ago - PRNewsWire

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Lightning Bolt™ 7 is the most advanced arterial thrombectomy system on the market Latest technology combines modulated aspiration with superior catheter design to maximize blood clot removal in a sing...

11 months ago - PRNewsWire

Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference

ALAMEDA, Calif. , May 24, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wed...

11 months ago - PRNewsWire

Penumbra, Inc. Reports First Quarter 2023 Financial Results

ALAMEDA, Calif. , May 2, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended Marc...

1 year ago - PRNewsWire

Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023

ALAMEDA, Calif. , April 4, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2023 after market clos...

1 year ago - PRNewsWire

Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality

Penumbra enters a three-year collaboration with VHA Office of Healthcare Innovation and Learning to test, co-develop and scale virtual reality solutions Collaboration to develop and implement therapy ...

1 year ago - PRNewsWire

Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder

Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o...

1 year ago - CNBC Television

Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

ALAMEDA, Calif. , Feb. 23, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and ful...

1 year ago - PRNewsWire

Penumbra, Inc. to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference

ALAMEDA, Calif. , Feb. 16, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Co...

1 year ago - PRNewsWire